A
Abeona Therapeutics D
D
ABEO
4.87500
USD
0.01
(0.25%)
مغلق
حجم التداول
18,619
الربح لكل سهم
1
العائد الربحي
-
P/E
8
حجم السوق
264,182,885
الأخبار المقالات
العنوان: Abeona Therapeutics
القطاع: Healthcare
الصناعة: Biotechnology
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.